JP2022509206A5 - - Google Patents

Info

Publication number
JP2022509206A5
JP2022509206A5 JP2021529827A JP2021529827A JP2022509206A5 JP 2022509206 A5 JP2022509206 A5 JP 2022509206A5 JP 2021529827 A JP2021529827 A JP 2021529827A JP 2021529827 A JP2021529827 A JP 2021529827A JP 2022509206 A5 JP2022509206 A5 JP 2022509206A5
Authority
JP
Japan
Application number
JP2021529827A
Other languages
Japanese (ja)
Other versions
JPWO2020112905A5 (https=
JP2022509206A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/063451 external-priority patent/WO2020112905A1/en
Publication of JP2022509206A publication Critical patent/JP2022509206A/ja
Publication of JP2022509206A5 publication Critical patent/JP2022509206A5/ja
Publication of JPWO2020112905A5 publication Critical patent/JPWO2020112905A5/ja
Pending legal-status Critical Current

Links

JP2021529827A 2018-11-28 2019-11-26 Magl阻害剤による疾病の治療方法 Pending JP2022509206A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862772554P 2018-11-28 2018-11-28
US62/772,554 2018-11-28
PCT/US2019/063451 WO2020112905A1 (en) 2018-11-28 2019-11-26 Methods of treating disease with magl inhibitors

Publications (3)

Publication Number Publication Date
JP2022509206A JP2022509206A (ja) 2022-01-20
JP2022509206A5 true JP2022509206A5 (https=) 2022-11-28
JPWO2020112905A5 JPWO2020112905A5 (https=) 2022-11-28

Family

ID=70851863

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021529827A Pending JP2022509206A (ja) 2018-11-28 2019-11-26 Magl阻害剤による疾病の治療方法

Country Status (15)

Country Link
US (1) US20220031676A1 (https=)
EP (1) EP3886844A4 (https=)
JP (1) JP2022509206A (https=)
KR (1) KR20210097734A (https=)
CN (1) CN113347971A (https=)
AU (1) AU2019389017B2 (https=)
BR (1) BR112020015043A2 (https=)
CA (1) CA3120577A1 (https=)
CL (1) CL2021001363A1 (https=)
IL (1) IL283508A (https=)
MA (1) MA54313A (https=)
MX (1) MX2021006312A (https=)
SG (1) SG11202105320YA (https=)
WO (1) WO2020112905A1 (https=)
ZA (1) ZA202103975B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3630744T3 (da) 2017-05-23 2023-03-06 H Lundbeck As Pyrazol-magl-inhibitorer
US10927105B1 (en) 2017-05-23 2021-02-23 Lundbeck La Jolla Research Center, Inc. Pyrazole MAGL inhibitors
CN117177744A (zh) 2021-01-29 2023-12-05 塞迪拉治疗股份有限公司 Cdk2抑制剂及其使用方法
MX2023015436A (es) 2021-06-26 2024-02-21 Cedilla Therapeutics Inc Inhibidores de cdk2 y metodos de uso de los mismos.
WO2023006893A1 (en) 2021-07-30 2023-02-02 Confo Therapeutics N.V. Compounds for the treatment of pain, in particular neuropathic pain, and/or other diseases or disorders that are associated with at2r and/or at2r mediated signaling
CA3234430A1 (en) * 2021-11-02 2023-05-11 Samuel George ANDREW Crystalline forms of a monoacylglycerol lipase inhibitor
CA3242372A1 (en) 2021-12-29 2023-07-06 Psy Therapeutics, Inc. Inhibiting monoacylglycerol lipase (magl)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8455476B2 (en) * 2009-04-22 2013-06-04 Janssen Pharmaceutica, Nv Azetidinyl diamides as monoacylglycerol lipase inhibitors
US10093630B2 (en) * 2014-05-21 2018-10-09 Abide Therapeutics, Inc. Pyrazole compounds and methods of making and using same
US10570146B2 (en) * 2014-07-25 2020-02-25 Northeastern University Urea/carbamates FAAH MAGL or dual FAAH/MAGL inhibitors and uses thereof
WO2017087858A1 (en) * 2015-11-20 2017-05-26 Abide Therapeutics, Inc. Pyrazole compounds and methods of making and using same
CN108601769B (zh) * 2015-11-20 2021-09-03 H.隆德贝克有限公司 吡唑化合物及其制备和使用方法
KR20170128029A (ko) * 2016-05-13 2017-11-22 삼성에스디아이 주식회사 태양전지 전극 형성용 조성물 및 이로부터 제조된 전극
CN110198944A (zh) * 2017-01-23 2019-09-03 辉瑞大药厂 作为单酰基甘油脂肪酶抑制剂的杂环螺环化合物
DK3630744T3 (da) * 2017-05-23 2023-03-06 H Lundbeck As Pyrazol-magl-inhibitorer
US10927105B1 (en) * 2017-05-23 2021-02-23 Lundbeck La Jolla Research Center, Inc. Pyrazole MAGL inhibitors

Similar Documents

Publication Publication Date Title
BR112019017762A2 (https=)
BR112021018450A2 (https=)
BR112021016821A2 (https=)
BR112021017939A2 (https=)
BR112021016996A2 (https=)
JP2022509206A5 (https=)
BR112021008711A2 (https=)
BR112019016141A2 (https=)
BR112021013944A2 (https=)
BR112021018452A2 (https=)
BR112021018102A2 (https=)
BR112019016142A2 (https=)
BR112019016138A2 (https=)
BR112021018168A2 (https=)
BR112021018093A2 (https=)
BR112021017083A2 (https=)
BR112021015080A2 (https=)
BR112021012348A2 (https=)
BR112021018250A2 (https=)
BR112021018584A2 (https=)
BR112021013128A2 (https=)
BR112021018484A2 (https=)
BR112021017949A2 (https=)
BR112021018084A2 (https=)
BR112019016136A2 (https=)